BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 38363735)

  • 1. Impact of the trans-ancestry polygenic risk score on type 2 diabetes risk, onset age and progression among population in Taiwan.
    Wang SH; Huang YC; Cheng CW; Chang YW; Liao WL
    Am J Physiol Endocrinol Metab; 2024 May; 326(5):E547-E554. PubMed ID: 38363735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of a trans-ancestry polygenic risk score for type 2 diabetes in diverse populations.
    Ge T; Irvin MR; Patki A; Srinivasasainagendra V; Lin YF; Tiwari HK; Armstrong ND; Benoit B; Chen CY; Choi KW; Cimino JJ; Davis BH; Dikilitas O; Etheridge B; Feng YA; Gainer V; Huang H; Jarvik GP; Kachulis C; Kenny EE; Khan A; Kiryluk K; Kottyan L; Kullo IJ; Lange C; Lennon N; Leong A; Malolepsza E; Miles AD; Murphy S; Namjou B; Narayan R; O'Connor MJ; Pacheco JA; Perez E; Rasmussen-Torvik LJ; Rosenthal EA; Schaid D; Stamou M; Udler MS; Wei WQ; Weiss ST; Ng MCY; Smoller JW; Lebo MS; Meigs JB; Limdi NA; Karlson EW
    Genome Med; 2022 Jun; 14(1):70. PubMed ID: 35765100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ancestry effects on type 2 diabetes genetic risk inference in Hispanic/Latino populations.
    Chande AT; Rishishwar L; Conley AB; Valderrama-Aguirre A; Medina-Rivas MA; Jordan IK
    BMC Med Genet; 2020 Jun; 21(Suppl 2):132. PubMed ID: 32580712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide polygenic risk score for retinopathy of type 2 diabetes.
    Forrest IS; Chaudhary K; Paranjpe I; Vy HMT; Marquez-Luna C; Rocheleau G; Saha A; Chan L; Van Vleck T; Loos RJF; Cho J; Pasquale LR; Nadkarni GN; Do R
    Hum Mol Genet; 2021 May; 30(10):952-960. PubMed ID: 33704450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk assessment for colorectal cancer via polygenic risk score and lifestyle exposure: a large-scale association study of East Asian and European populations.
    Xin J; Du M; Gu D; Jiang K; Wang M; Jin M; Hu Y; Ben S; Chen S; Shao W; Li S; Chu H; Zhu L; Li C; Chen K; Ding K; Zhang Z; Shen H; Wang M
    Genome Med; 2023 Jan; 15(1):4. PubMed ID: 36694225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polygenic risk scores for the prediction of common cancers in East Asians: A population-based prospective cohort study.
    Ho PJ; Tan IB; Chong DQ; Khor CC; Yuan JM; Koh WP; Dorajoo R; Li J
    Elife; 2023 Mar; 12():. PubMed ID: 36971353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polygenic risk scores for cardiometabolic traits demonstrate importance of ancestry for predictive precision medicine.
    Kember RL; Verma SS; Verma A; Xiao B; Lucas A; Kripke CM; Judy R; Chen J; Damrauer SM; Rader DJ; Ritchie MD
    Pac Symp Biocomput; 2024; 29():611-626. PubMed ID: 38160310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of genome-wide polygenic risk scores for lipid traits and clinical applications for dyslipidemia, subclinical atherosclerosis, and diabetes cardiovascular complications among East Asians.
    Tam CHT; Lim CKP; Luk AOY; Ng ACW; Lee HM; Jiang G; Lau ESH; Fan B; Wan R; Kong APS; Tam WH; Ozaki R; Chow EYK; Lee KF; Siu SC; Hui G; Tsang CC; Lau KP; Leung JYY; Tsang MW; Kam G; Lau IT; Li JKY; Yeung VTF; Lau E; Lo S; Fung S; Cheng YL; Chow CC; Hu M; Yu W; Tsui SKW; Huang Y; Lan H; Szeto CC; Tang NLS; Ng MCY; So WY; Tomlinson B; Chan JCN; Ma RCW; ;
    Genome Med; 2021 Feb; 13(1):29. PubMed ID: 33608049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of polygenic risk score for triglyceride trajectory and diabetic complications in subjects with type 2 diabetes based on large electronic medical record data from Taiwan: a case control study.
    Liao WL; Huang YC; Chang YW; Cheng CF; Liu TY; Lu HF; Chen HL; Tsai FJ
    J Endocrinol Invest; 2024 May; ():. PubMed ID: 38795312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrating polygenic risk scores in the prediction of type 2 diabetes risk and subtypes in British Pakistanis and Bangladeshis: A population-based cohort study.
    Hodgson S; Huang QQ; Sallah N; ; Griffiths CJ; Newman WG; Trembath RC; Wright J; Lumbers RT; Kuchenbaecker K; van Heel DA; Mathur R; Martin HC; Finer S
    PLoS Med; 2022 May; 19(5):e1003981. PubMed ID: 35587468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk prediction and interaction analysis using polygenic risk score of type 2 diabetes in a Korean population.
    Song M; Kwak SH; Kim J
    Sci Rep; 2024 Mar; 14(1):6790. PubMed ID: 38514700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the performance of European-derived cardiometabolic polygenic risk scores in South-Asians and their interplay with family history.
    Hassanin E; Maj C; Klinkhammer H; Krawitz P; May P; Bobbili DR
    BMC Med Genomics; 2023 Jul; 16(1):164. PubMed ID: 37438803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of polygenic risk scores to differentiate between type 1 and type 2 diabetes.
    Shoaib M; Ye Q; IglayReger H; Tan MH; Boehnke M; Burant CF; Soleimanpour SA; Gagliano Taliun SA
    Genet Epidemiol; 2023 Jun; 47(4):303-313. PubMed ID: 36821788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trans-ancestry polygenic models for the prediction of LDL blood levels: an analysis of the United Kingdom Biobank and Taiwan Biobank.
    Hassanin E; Lee KH; Hsieh TC; Aldisi R; Lee YL; Bobbili D; Krawitz P; May P; Chen CY; Maj C
    Front Genet; 2023; 14():1286561. PubMed ID: 38075701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Menarche-a journey into womanhood: age at menarche and health-related outcomes in East Asians.
    Chiou JS; Lin YJ; Chang CY; Liang WM; Liu TY; Yang JS; Chou CH; Lu HF; Chiu ML; Lin TH; Liao CC; Huang SM; Chou IC; Li TM; Huang PY; Chien TS; Chen HR; Tsai FJ
    Hum Reprod; 2024 Jun; 39(6):1336-1350. PubMed ID: 38527428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The contribution of functional HNF1A variants and polygenic susceptibility to risk of type 2 diabetes in ancestrally diverse populations.
    Stalbow LA; Preuss MH; Smit RAJ; Chami N; Bjørkhaug L; Aukrust I; Gloyn AL; Loos RJF
    Diabetologia; 2023 Jan; 66(1):116-126. PubMed ID: 36216889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of optimal methods and ancestries for calculating polygenic risk scores in East Asian population.
    Kim DJ; Kang JH; Kim JW; Cheon MJ; Kim SB; Lee YK; Lee BC
    Sci Rep; 2023 Nov; 13(1):19195. PubMed ID: 37932343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What is the contribution of two genetic variants regulating VEGF levels to type 2 diabetes risk and to microvascular complications?
    Bonnefond A; Saulnier PJ; Stathopoulou MG; Grarup N; Ndiaye NC; Roussel R; Nezhad MA; Dechaume A; Lantieri O; Hercberg S; Lauritzen T; Balkau B; El-Sayed Moustafa JS; Hansen T; Pedersen O; Froguel P; Charpentier G; Marre M; Hadjadj S; Visvikis-Siest S
    PLoS One; 2013; 8(2):e55921. PubMed ID: 23405237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy.
    Perais J; Agarwal R; Evans JR; Loveman E; Colquitt JL; Owens D; Hogg RE; Lawrenson JG; Takwoingi Y; Lois N
    Cochrane Database Syst Rev; 2023 Feb; 2(2):CD013775. PubMed ID: 36815723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide polygenic risk score for type 2 diabetes in Indian population.
    Pemmasani SK; Atmakuri S; Acharya A
    Sci Rep; 2023 Jul; 13(1):11568. PubMed ID: 37463971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.